The Impact of the COVID-19 Pandemic on Parkinson’s Disease: Hidden Sorrows and Emerging Opportunities
Authors
Discussion
Loading...
Member takes
Implication
Clinical commentary highlights elevated respiratory risks from COVID-19 in Parkinson's disease, suggesting heightened vulnerability to severe infection and disruptions during pandemic lockdowns.
Key Points
- To examine the physiological vulnerability, potential respiratory complications, and healthcare disruptions faced by individuals with Parkinson's disease during the COVID-19 pandemic.
- Clinical review and perspective evaluating pathophysiological intersections between SARS-CoV-2 infection and Parkinson's disease.
- Assessment of how nationwide containment measures, including social isolation and lockdown protocols, affect chronic disease management.
- Advanced Parkinson's disease compromises the respiratory system and inherently increases pneumonia risk, predisposing patients to worse respiratory outcomes from SARS-CoV-2 infection.
- Pandemic control measures such as physical distancing and isolation pose secondary threats by disrupting ongoing neurological care, physical rehabilitation, and daily activity.
Cite This Study
Helmich et al. (2020) studied this question.